Report copyright - Targeted Therapies for Advanced NSCLCimg.medscape.com/images/867/844/867844_slides.pdfSep 15, 2011 · JO25567 Phase II Trial Erlotinib +/- Bevacizumab •Stage IIIB/IV NSCLC •EGFR
Please pass captcha verification before submit form
Please pass captcha verification before submit form